Chemical
At BSKB, we combine industry knowledge with intellectual property law expertise. That’s why all of the intellectual property law attorneys and technical advisors in our Chemical Practice Group have either undergraduate or graduate degrees in chemistry or chemical engineering. Many of us began our careers as patent examiners at the United States Patent and Trademark Office (USPTO), chemists, process engineers or professors.
Our diverse technical backgrounds and experiences help us to better understand complex chemistries and highly technical engineering issues. We prepare and prosecute hundreds of chemical patent applications in the USPTO, and various foreign countries, each year.
We represent pharmaceutical and chemical companies around the world and have prosecuted chemical patents in the areas of polymer chemistry, chemical processing and synthesis, catalysts, materials science, organic and inorganic chemistry, pharmaceutical chemistry, physical chemistry and nanotechnology.
Attorneys and Professionals
Related Articles
-
December 26, 2022
Key U.S. Supreme Court Developments in 2022 and Outlook for 2023
IPWatchdog
As the 2022 year comes to an end, Dr. Hailey Bureau reflects on the Intellectual Property industry and the key SCOTUS decisions of 2022 that impacted patent and trademark law.
-
July 1, 2022
"Pharma Patents Under Fire From Federal Circuit, Petitions Say"
Bloomberg Law
BSKB's Hailey R. Bureau, Ph.D., was quoted in an article for Bloomberg Law regarding recent rulings by the US Court of Appeals for the Federal Circuit regarding strict enforcement of certain Patent Act provisions. These rulings regarding Section 112(a), a written description requirement and an enablement standard, have created a high burden for Applicants in the life science industry to overcome.
Related Presentations
-
November 15, 2023
The means-plus-function issue in WSOU Investments LLC v. Google LLC
-
October 25, 2023
In re Cellect: Patent Term Adjustment (PTA) under 35 USC § 154; Patent Term Extension (PTE) under 35 USC § 156; Obviousness-Type Double Patenting (OTDP); and Terminal Disclaimers (TD)
-
September 20, 2023
A review of the analogous art test: Sanofi v. Mylan, No. 21-1981 (Fed. Cir. May 9, 2023)
-
May 24, 2023
UCB v. Actavis Laboratories – Relying on range limitations in claims to distinguish from prior art
Related News
-
September 5, 2023
BSKB Lawyers Recognized as Best Lawyers® Award Recipients
Birch, Stewart, Kolasch & Birch, LLP is pleased to announce that 4 lawyers have been included in the 2024 edition of The Best Lawyers in America®.
-
June 6, 2023
USPTO DOCX Announcement
The U.S. Patent and Trademark Office (USPTO) has delayed the implementation of the non-DOCX filing surcharge until January 17, 2024. In addition, the option to upload a backup PDF version with the DOCX filing of the application has been extended until further notice.